A Peer-Reviewed Journal
November 2013 • Volume 2 • Number 7
BIOMARKERS • IMMUNOTHERAPY • TARGETED THERAPIES • DIAGNOSTICS
PM O
The official publication of
Global biomarkers Consortium Clinical Approaches
TM
to Targeted Technologies
TM
Personalized Medicine in Oncology TM
SPECIAL REPORT Second Annual Global Biomarkers Consortium Conference Highlights…...............................Page 366
INTERVIEW WITH THE INNOVATORS Multiple Myeloma and the MMRF CoMMpass Study: Revolutionizing Clinical Trial Data Dissemination: A Panel Discussion With the Researchers..................................................Page 380
HIGHLIGHTS FROM EHA 2013 CME Faculty Perspectives. Advances in the Treatment of Chronic Myeloid Leukemia.......................Page 388
MULTIPLE MYELOMA CME Considerations in Multiple Myeloma. Ask the Experts: The Role of Transplantation ...........Page 396
NSCLC CASE STUDY Personalizing Therapy in the Management of Recurrent Non–Small Cell Lung Cancer: Case Study of a Patient With an EGFR Mutation….....................................................Page 410
THE LAST WORD To PARP or Not to PARP – What Is the Question? Part 2.............................................................Page 413
www.PersonalizedMedOnc.com © 2013 Green Hill Healthcare Communications, LLC
In partnership with